A proposal for basic management of HIV disease in West Africa: Use of clinical staging and haemogram data

International Journal of STD and AIDS

Volumn 9, Issue 8, 1998, Pages 463-470

  Ledru, E ^a,d   Diagbouga, S ^a   Meda, N ^a   Sanou, P T ^b   Dahourou, H ^c   Ledru, S ^a   Dembele A ^b   Zoubga, A ^c   Durand, G ^c  

^a CENTRE MURAZ   (Burkina Faso)

^b Dir Prov de la S du Houet ^*  (Burkina Faso)

^c Centre Hospitalier National Souro Sanou   (Burkina Faso)

^d INSTITUT PASTEUR   (France)

Author keywords

CD4+ T lymphocytes; Haemogram; HIV associated diseases; Monitoring; West Africa

Indexed keywords

CD4 ANTIGEN;

ADULT; AFRICA; ARTICLE; CACHEXIA; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SCREENING TEST; SKIN DISEASE; THROMBOCYTE COUNT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; BURKINA FASO; DEVELOPING COUNTRIES; DISEASES; EXAMINATIONS AND DIAGNOSES; FRENCH SPEAKING AFRICA; HIV INFECTIONS; HIV SERODIAGNOSIS; LABORATORY EXAMINATIONS AND DIAGNOSES; RESEARCH REPORT; SIGNS AND SYMPTOMS; VIRAL DISEASES; WESTERN AFRICA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BURKINA FASO; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; EOSINOPHILS; HEMOGLOBINS; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT; PLATELET COUNT; TUBERCULOSIS, PULMONARY;

EID: 0031822481     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981922638     Document Type: Article

References (40)

1. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Data as at 20 November 1996. Wkly Epidem Rec 1997;71:361-8
2. Buvé A, Caraël M, Hayes R, Robinson JN. Variations in HIV prevalence between urban areas in sub-Saharan Africa: do we understand them? AIDS 1995;9(suppl A):S103-9
3. World Health Organization. HIV/AIDS: the global epidemic. December 1996. Wkly Epidem Rec 1997;72:17-24
4. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993;7:1569-79
5. Rochereau A, Lankoande S, Yameogo M, et al. Surveillance sérologique des infections à VIH dans trois populations sentinelles à Bobo-Dioulasso (résumé TA105). Vlème Conférence Internationale sur le SIDA en Afrique, Dakar, Sénégal, 16-19 Décembre 1991
6. De Cock KM, Barrere B, Diaby L, et al. AIDS - the leading cause of adult death in the West African city of Abidjan, Côte d'Ivoire. Science 1990;249:793-6
7. Denis F, Barin F, Gershy-Damet G, et al. Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast. Lancet 1987;1:408-11
8. Djomand G, Greenberg AE, Sassan-Morokro M, et al. The epidemic of HIV/AIDS in Abidjan, Côte d'Ivoire: a review of data collected by Project RETRO-CI from 1987 to 1993. J Acquir Immune Defic Syndr 1995;10:358-65
9. Cartoux M, Meda N, Van de Perre P, et al. HIV testing and counseling in African pregnant women in the context of interventions to reduce mother-to-child transmission (abstract ThC411). XIth International Conference on AIDS, Vancouver, 7-12 July 1996
10. Taverne B. Management of HIV-positive and full-blown AIDS patients in the rural environment of Burkina Faso. Cahiers Santé 1997;7:177-86
11. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19
12. DeCock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992;268:1581-7
13. Mukadi Y, Perriens JH, St Louis ME, et al. Spectrum of immunodeficiency in HIV-1 infected patients with pulmonary tuberculosis in Zaire. Lancet 1993;342:143-6
14. Comité National de Lutte contre le Sida du Burkina Faso et Groupe de travail pour la lutte contre le Sida de Bobo-Dioulasso. Guide pour la prise en Charge Clinique et Psychosociale de l'Adulte infecté par le Virus de l'Immunodéficience Humaine. Ouagadougou 1995
15. Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet 1996;348:659-63
16. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Wkly Epidem Rec 1990;65:281-3
17. Belec L, Gherardi R, Georges AJ, et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol 1989;236:411-14
18. Colebunders R, Mann JM, Francis H, et al. Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection. AIDS 1987;1:117-21
19. Del Amo J, Petruckevitch A, Phillips AN, et al. Spectrum of disease in Africans with AIDS in London. AIDS 1996; 10:1563-9
20. Morgan D, Maude GH, Malamba SS, et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997;350:245-50
21. Ledru E, Diagbouga S, Ledru S, et al. A study of toxoplasma and cytomegalovirus serology in tuberculosis and in HIV-infected patients in Burkina Faso. Acta Tropica 1995;59:149-54
22. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993;58:417-24
23. Zangerle R, Reibnegger G, Wachter H, Fuchs D. Weight loss in HIV-1 infection is associated with immune activation. AIDS 1993;7:175-81
24. DuPont HL, Marshall GD. HIV-associated diarrhoea and wasting. Lancet 1995;346:352-6
25. Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996;348:379-83
26. Gilles HM. Normal haematological values in tropical areas. Clin Haematol 1981;10:697-706
27. Anglaret X, Diagbouga S, Mortier E, et al. CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr 1997;14:361-7
28. Grant AD, Djomand G, Smets P, et al. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire. AIDS 1997;11:1357-64
29. Schlechter M, Zadjdenverg R, Lameirao Machado L, Pinto ME, Lima LAA, Perez MA. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J Acquir Immune Defic Syndr 1994;7:163-8
30. + lymphocyte count <50/μl. J Infect Dis 1995;171:829-36
31. Blatt SP, McCarthy WF, Bucko-Krasnicka B, et al. Multi-variate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis 1995;171:837-44
32. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidem Rec 1990;65:221-8
33. + lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr 1995;8:386-91
34. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996;174: 615-18
35. Ledru E, Diagbouga S, Tranchot-Diallo J, et al. Eosinophils: a putative marker of immunodepression in HIV-infected African patients with tuberculosis? Trans R Soc Trop Med Hyg 1994;88:117-18
36. Sanchez-Borges M, Orozco A, Di Biagio E, et al. Eosinophilia in early-stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993;92:494-5
37. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35
38. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72
39. Goletti D, Weissman D, Jackson RW, et al. Effect of mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-8
40. Hui KP, Chin NK, Chan TB, Tan WC. Platelet count as an independent predictor differentiating between tuberculosis and non-tuberculosis pneumonia. Tuber Lung Dis 1994; 75:157